Third Wave Technologies and Digene Corp. are back in court, this time for a dispute over a patent covering a single type of the human papilloma virus. Digene is suing Third Wave, which denies that it's in violation of the patent, in the U.S. District...
Epic Systems is one of the reasons that Wisconsin is in the forefront of electronic medical records, and the company would like to add 1,500 more individual offices to its Verona campus. That number is roughly 500 more than the 2,500 employees it now has...
A U.S. District court in Wisconsin has issued an injunction to enjoin Abbott Laboratories from any further sales of products that infringe on a patent held by Innogenetics, a Belgian-based biopharmaceutical firm. It is the latest in a series of court victories for Innogenetics,...
The Democratic Party now controls both houses of Congress, and it was reflected in a strong vote in the House of Representatives in favor of lifting President Bush's restrictions on federal funding for embryonic stem cell research. The vote, however, was still well short of...
Apple's Steve Jobs has managed, at least temporarily, to change the subject from the backdating of stock options to a revolutionary new multimedia product, the iPhone. Just how revolutionary is the iPhone, and who might it put out of business? Columnist James Carlini offers a...
Continuing its pattern of growth by acquisition, a Chicago-based data security provider has purchased SecurePipe, an Illinois managed security provider with 25 employees in Wisconsin. AmbironTrustWave says it will use SecurePipe's Madison-based location as its primary network operation center....
Governor Jim Doyle has sent a letter to all members of Wisconsin's Congressional delegation urging them to vote to lift president George W. Bush's restrictions on embryonic stem cell research and pass the Stem Cell Research Enhancement Act of 2007. The legislation would lift current...
BioSystem Development, a Middleton biotech firm that has developed a new system for protein analysis, will receive more than $700,000 in equity funding from two Wisconsin angel investment groups....
Mirus Bio, a Madison biotechnology company, has entered into a milestone agreement with pharmaceutical giant Pfizer to develop gene suppression techniques for the development of drugs. The agreement will enable Mirus to further develop two platform technologies used to deliver nucleic acid to the bloodstream...
NimbleGen, a Madison biotechnology company that manufactures microarrays for use in scientific research, has entered into a commercial relationship with a British company that also develops microarrays....